Aprea Therapeutics

APRENasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$8.053 M

$0.65 +2.81%

Close of 7 Aug 2026

Revenue

—

Not reported

Earnings

-$12.6M

Loss-making

Shares outstanding

11,452,452

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations — ranked by market cap

All 501 →

#441Kairos PharmaKAPA$8.26M
#442Traws PharmaTRAW$8.10M
#443Aprea TherapeuticsAPRE$8.05M
#444Ensysce BiosciencesENSC$7.99M
#445Moleculin BiotechMBRX$7.98M

Where these numbers come from

Share counts and financials for Aprea Therapeutics are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.